scholarly article | Q13442814 |
P2093 | author name string | J J Mekalanos | |
D T Beattie | |||
S B Calderwood | |||
P A Carroll | |||
T Hyman | |||
J R Butterton | |||
K P Killeen | |||
C L Gardel | |||
P2860 | cites work | Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity | Q40158183 |
Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery | Q40186741 | ||
Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system | Q41028623 | ||
An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels | Q43806909 | ||
M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration | Q45717806 | ||
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon | Q54696474 | ||
Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
Carboxy-terminal peptides from the B subunit of Shiga toxin induce a local and parenteral protective effect | Q68538847 | ||
Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor | Q68930307 | ||
Duration of infection-derived immunity to cholera | Q70831304 | ||
Duplication and amplification of toxin genes in Vibrio cholerae | Q71063547 | ||
Intestinal antibody responses after immunisation with cholera B subunit | Q72520039 | ||
Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains | Q72746081 | ||
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development | Q28485732 | ||
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR | Q29615324 | ||
Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 | ||
Identification of a lacZ gene in Vibrio cholerae | Q33231724 | ||
Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects | Q33491823 | ||
Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response | Q33926950 | ||
A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit | Q35104239 | ||
Use of genetic recombination as a reporter of gene expression | Q35126408 | ||
Cholera in the Americas. Guidelines for the clinician | Q35310981 | ||
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. | Q36262564 | ||
Cloning of the Vibrio cholerae recA gene and construction of a Vibrio cholerae recA mutant | Q36282476 | ||
Effect of a recA mutation on cholera toxin gene amplification and deletion events | Q36282496 | ||
Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette | Q36346932 | ||
Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. | Q36349737 | ||
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans | Q36355455 | ||
Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin | Q36973479 | ||
Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. | Q36974461 | ||
Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis. | Q36975350 | ||
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector | Q36989608 | ||
Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits | Q36992532 | ||
Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo. | Q37100429 | ||
Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. | Q37107796 | ||
Enzyme-linked immunosorbent assay for shigella toxin. | Q37207255 | ||
Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae | Q37395794 | ||
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae | Q40149193 | ||
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection | Q40152851 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Vibrio cholerae | Q160821 |
P304 | page(s) | 2689-2696 | |
P577 | publication date | 1995-07-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Heterologous antigen expression in Vibrio cholerae vector strains | |
P478 | volume | 63 |
Q64900677 | A live vaccine rapidly protects against cholera in an infant rabbit model. |
Q35086704 | A low gastric pH mouse model to evaluate live attenuated bacterial vaccines |
Q35609627 | A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. |
Q35191261 | A novel peptidoglycan binding protein crucial for PBP1A-mediated cell wall biogenesis in Vibrio cholerae |
Q35548328 | A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins |
Q33752525 | A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. |
Q52684483 | A self-assembling whole cell vaccine antigen presentation platform. |
Q34004479 | Classical and El Tor biotypes of Vibrio cholerae differ in timing of transcription of tcpPH during growth in inducing conditions |
Q35548775 | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains |
Q39108492 | Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies |
Q46652410 | Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation |
Q36480147 | Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit |
Q34005028 | Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision |
Q35526942 | Development of a germfree mouse model of Vibrio cholerae infection. |
Q41928379 | Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector. |
Q24533466 | Diarrheagenic Escherichia coli |
Q64258842 | Endopeptidase Regulation as a Novel Function of the Zur-Dependent Zinc Starvation Response |
Q37002887 | Exploiting cholera vaccines as a versatile antigen delivery platform |
Q59060436 | Filamentous phage integration requires the host recombinases XerC and XerD |
Q30363428 | Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains |
Q34000827 | In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae |
Q35552261 | Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae |
Q35551627 | Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain |
Q24684056 | RNase E-dependent processing stabilizes MicX, a Vibrio cholerae sRNA |
Q55042601 | Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. |
Q42204032 | Substrate specificity of an elongation-specific peptidoglycan endopeptidase and its implications for cell wall architecture and growth of Vibrio cholerae |
Q30327646 | The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. |
Q74386296 | The interaction of the Vibrio cholerae transcription factors, Fur and IrgB, with the overlapping promoters of two virulence genes, irgA and irgB |
Q36835985 | Vibrio cholerae CytR is a repressor of biofilm development |
Q30842231 | Vibrio cholerae VibF is required for vibriobactin synthesis and is a member of the family of nonribosomal peptide synthetases |
Q33995198 | pepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae |
Search more.